Growth Metrics

West Pharmaceutical Services (WST) Tax Provisions (2016 - 2026)

West Pharmaceutical Services has reported Tax Provisions over the past 18 years, most recently at $44.7 million for Q1 2026.

  • Quarterly Tax Provisions rose 85.48% to $44.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $142.2 million through Mar 2026, up 23.44% year-over-year, with the annual reading at $121.6 million for FY2025, 13.12% up from the prior year.
  • Tax Provisions was $44.7 million for Q1 2026 at West Pharmaceutical Services, up from $33.3 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $44.7 million in Q1 2026 and troughed at $16.4 million in Q1 2024.
  • The 5-year median for Tax Provisions is $30.2 million (2025), against an average of $30.0 million.
  • Biggest five-year swings in Tax Provisions: tumbled 37.07% in 2024 and later soared 85.48% in 2026.
  • Tracing WST's Tax Provisions over 5 years: stood at $28.9 million in 2022, then increased by 19.38% to $34.5 million in 2023, then rose by 6.67% to $36.8 million in 2024, then dropped by 9.51% to $33.3 million in 2025, then surged by 34.23% to $44.7 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $44.7 million, $33.3 million, and $34.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.